These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33283628)

  • 1. Nivolumab for the salvage treatment of desperate germ cell tumor: A case report.
    Aksun MS; Ucgul E; Sahin TK; Guven DC; Aksoy S
    J Oncol Pharm Pract; 2021 Sep; 27(6):1516-1519. PubMed ID: 33283628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to anti-programmed cell death protein-1 antibodies in men treated for platinum refractory germ cell cancer relapsed after high-dose chemotherapy and stem cell transplantation.
    Zschäbitz S; Lasitschka F; Hadaschik B; Hofheinz RD; Jentsch-Ullrich K; Grüner M; Jäger D; Grüllich C
    Eur J Cancer; 2017 May; 76():1-7. PubMed ID: 28262583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of pembrolizumab in patients with platinum refractory germ-cell tumors: a Hoosier Cancer Research Network Study GU14-206.
    Adra N; Einhorn LH; Althouse SK; Ammakkanavar NR; Musapatika D; Albany C; Vaughn D; Hanna NH
    Ann Oncol; 2018 Jan; 29(1):209-214. PubMed ID: 29045540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Autologous Stem Cell Transplantation (ASCT) in Relapsed/Refractory Germ Cell Tumors: Single Center Experience from Turkey.
    Yildiz F; Durnali A; Eraslan E; Ilhan A; Tufan G; Aslan F; Arslan UY; Alkis N; Demirci U; Altuntas F; Oksuzoglu B
    Urol J; 2020 Aug; 17(5):497-500. PubMed ID: 32869258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy: last bullet in platinum refractory germ cell testicular cancer.
    Semaan A; Haddad FG; Eid R; Kourie HR; Nemr E
    Future Oncol; 2019 Feb; 15(5):533-541. PubMed ID: 30624089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poor prognosis of retroperitoneal mixed extragonadal germ cell tumors in an HIV-infected man with severe immunosuppression and bilateral cryptorchidism: a case report.
    Li R; Li H
    BMC Cancer; 2019 Mar; 19(1):244. PubMed ID: 30885154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Effectiveness of Surveillance, Primary Chemotherapy, Radiotherapy and Retroperitoneal Lymph Node Dissection for the Management of Early Stage Testicular Germ Cell Tumors: A Systematic Review.
    Pierorazio PM; Cheaib JG; Patel HD; Gupta M; Sharma R; Zhang A; Tema G; Bass EB
    J Urol; 2021 Feb; 205(2):370-382. PubMed ID: 32915080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Management of Refractory Germ Cell Tumors.
    Abughanimeh O; Teply BA
    Curr Oncol Rep; 2021 Jul; 23(9):101. PubMed ID: 34269906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platinum-refractory germ cell tumors: an update on current treatment options and developments.
    Oing C; Alsdorf WH; von Amsberg G; Oechsle K; Bokemeyer C
    World J Urol; 2017 Aug; 35(8):1167-1175. PubMed ID: 27449639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Durable Response to Immune Checkpoint Blockade in a Platinum-Refractory Patient With Nonseminomatous Germ Cell Tumor.
    Chi EA; Schweizer MT
    Clin Genitourin Cancer; 2017 Oct; 15(5):e855-e857. PubMed ID: 28465048
    [No Abstract]   [Full Text] [Related]  

  • 11. Promising novel therapies for relapsed and refractory testicular germ cell tumors.
    Kozakova K; Mego M; Cheng L; Chovanec M
    Expert Rev Anticancer Ther; 2021 Jan; 21(1):53-69. PubMed ID: 33138660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [High dose chemotherapy with autologous stem-cell support in germ cell tumors: The Instituto Português de Oncologia de Lisboa Francisco Gentil Series].
    Brito M; Sanchez P; Velho S; Miranda N; Leal da Costa F; Ferreira I; Teixeira G; Guimarães A; Abecasis M; Passos Coelho JL
    Acta Med Port; 2011; 24(4):533-44. PubMed ID: 22521011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
    Bokemeyer C; Harstrick A; Beyer J; Metzner B; Rüther U; Hartmann JT; Holstein K; Derigs HG; de Wit R; Casper J; Schöffski P; Kührer I; Illiger HJ; Kempf B; Reichle A; Föller A; Hossfeld DK; Fischer JT; Berdel WE; Gerhartz HH; Kirchner H; Pflüger KH; Ostermann H; Kanz L; Schmoll HJ
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Management of Refractory Germ Cell Tumors and Future Directions.
    Allen JC; Kirschner A; Scarpato KR; Morgans AK
    Curr Oncol Rep; 2017 Feb; 19(2):8. PubMed ID: 28220447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors.
    Einhorn LH; Williams SD; Chamness A; Brames MJ; Perkins SM; Abonour R
    N Engl J Med; 2007 Jul; 357(4):340-8. PubMed ID: 17652649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of high-dosage chemotherapy with autologous hematopoietic stem cell transplantation as a first-line therapy for the patients with poor-prognosis testicular tumors].
    Marjanović S; Cerović S; Brajusković G
    Vojnosanit Pregl; 2005 Mar; 62(3):213-8. PubMed ID: 15790050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive and timely chemotherapy, the key of success in testicular cancer.
    Fléchon A; Culine S; Droz JP
    Crit Rev Oncol Hematol; 2001 Jan; 37(1):35-46. PubMed ID: 11164717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation for refractory germ cell tumors: does it really make a difference?
    Nieto Y
    Curr Oncol Rep; 2013 Jun; 15(3):232-8. PubMed ID: 23494829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a VEGFR2/PDGFRβ/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trial.
    Subbiah V; Meric-Bernstam F; Mills GB; Shaw KR; Bailey AM; Rao P; Ward JF; Pagliaro LC
    J Hematol Oncol; 2014 Aug; 7():52. PubMed ID: 25085632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival outcomes and toxicity in patients 40 years old or older with relapsed metastatic germ cell tumors treated with high-dose chemotherapy and peripheral blood stem cell transplantation.
    Agrawal V; Abonour R; Abu Zaid M; Althouse SK; Ashkar R; Albany C; Hanna NH; Einhorn LH; Adra N
    Cancer; 2021 Oct; 127(20):3751-3760. PubMed ID: 34260067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.